PCI vs. CABG in the Treatment of Unprotected Left Main Stenosis (LeftMain/NOBLE)
Nordic-Baltic-British Left Main Revascularization Study (NOBLE)
Sponsor: Evald Hoej Christiansen
Listed as NCT01496651, this NA trial focuses on Coronary Artery Disease and remains ongoing. Sponsored by Evald Hoej Christiansen, it has been updated 9 times since 2008, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Jun 2025 — Present [monthly]
Active Not Recruiting NA
-
Sep 2024 — Jun 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Feb 2021 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting NA
▶ Show 4 earlier versions
-
Dec 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Dec 2018 — Dec 2019 [monthly]
Active Not Recruiting NA
Phase: PHASE4 → NA
-
Jun 2018 — Dec 2018 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
First recorded
Nov 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Evald Hoej Christiansen
For direct contact, visit the study record on ClinicalTrials.gov .